Johnson & Johnson faces $400 million in tariff-related costs, primarily from China, impacting medical technology.

From Yahoo Finance: 2025-04-15 11:20:00

Johnson & Johnson expects $400 million in tariff costs this year, primarily affecting its medical technology unit due to tariffs against China and retaliatory tariffs. The estimate includes impacts from aluminum, steel, Canada, and Mexico tariffs but not pharmaceutical tariffs. CEO warns of potential supply chain issues and advocates for tax policy over tariffs to boost U.S. manufacturing. The company plans to invest $55 billion over four years to produce all advanced medicines in the U.S.

Read more: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China